Brad Stefanovic
About Brad Stefanovic
Brad Stefanovic serves as the Head of Clinical Operations and Vice President at Ocugen, with extensive experience in clinical operations across various organizations. He holds a PhD in Clinical Exercise Physiology and has worked in leadership roles at multiple companies, including Pro-ficiency and Aura Biosciences.
Work at Ocugen
Brad Stefanovic serves as the Head of Clinical Operations and Vice President at Ocugen. He has held this position since 2022, contributing to the company's clinical operations in both Greater Philadelphia and New York City. His role involves overseeing clinical strategies and ensuring the successful execution of clinical trials.
Current Role at Pro-ficiency
In addition to his role at Ocugen, Brad Stefanovic is the Head of Clinical Innovation at Pro-ficiency, a position he has held since 2023. This role emphasizes his commitment to advancing clinical practices and innovation within the field.
Previous Experience in Clinical Operations
Brad Stefanovic has extensive experience in clinical operations, having previously worked as Vice President of Clinical Operations at Aura Biosciences from 2021 to 2022. His career also includes significant roles at BioTissue, where he served as Senior Director and Director of Clinical Operations in 2021, and as Senior Program Manager at Syntactx from 2016 to 2018.
Educational Background
Brad Stefanovic earned his PhD in Clinical Exercise Physiology and Vascular Disease from the University of the Sunshine Coast, where he also completed a Bachelor of Science in Clinical Exercise Physiology. His academic journey included a role as a Lecturer and Tutor at the same university, further solidifying his expertise in the field.
Leadership and Philosophy
Brad Stefanovic embraces a leadership mentality shaped by his active family environment. He draws inspiration from Jim Valvano's philosophy on living a full day, which reflects his commitment to making meaningful contributions in clinical research and operations.